Hookipa proposes IPO as its cancer vaccines head towards the clinic

Infectious disease and cancer vaccine company Hookipa proposed Friday to raise up to $86.3 million in an IPO on NASDAQ.

Hookipa Pharma Inc. (New York, N.Y.) is developing vaccines using its VaxWave and TheraT viral vector platforms, both of which are arenavirus-based...